BioSpace News Archive

On International Overdose Awareness Day, community encouraged to learn about additional treatment options to help save lives.

AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, today announced that members of its senior management team are scheduled to participate in three investor conferences in September.

Debbie’s Dream Foundation: Curing Stomach Cancer welcomed four new members during its 2022 Board Installation and Appreciation Dinner on August 16, 2022.

Recordati Rare Diseases Inc. announces the publication of the long-term outcomes from the open-label extension period of the Phase III LINC 3 study of ISTURISA in The European Journal of Endocrinology.

MiNK Therapeutics, Inc. announced that the Company will participate in two investor conferences in September.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original [15 µg] and Omicron BA.4/BA.5 [15 µg]) for individuals ages 12 years and older.

Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cell and gene therapies in oncology, neurology, and virology, is pleased to announce the appointment of Victor Sordillo, PE, CSP, MBA, to Tevogen’s Corporate Advisory Board.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that it has received emergency use authorization from the U.S. Food and Drug Administration for its BA.4/.5 Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.222.

Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Company”), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that it has priced its previously announced proposed offering (the “Offering”) of units of the Company (“Units”).